ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a
ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a close. The company has already set aside $37.1 million in prior financial periods to cover the full cost of the judgment, which was awarded in 1996 (SCAN 6/5/96). SRI filed the suit in 1991, charging ATL with violating a patent SRI received in 1977 for tracking filter circuits used in ATL's Ultramark 4, Ultramark 5, and ADR 4000 ultrasound scanners, all of which have been discontinued. The relevant patent expired in 1994, according to ATL.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.